Neurocrine Study Shows Evolving Care Needs Across Lifespan in Classic Congenital Adrenal Hyperplasia

Neurocrine Biosciences announced real-world study findings showing that classic congenital adrenal hyperplasia creates evolving clinical and daily-life challenges across patients’ lifetimes. Results will be presented at the Endocrine Nurses Society Annual Symposium, Oct. 16-17, 2026, in Phoenix. Patient records showed childhood growth concerns shifting toward reproductive needs in young adulthood, with broader health concerns emerging later. Treatment management demands persisted across life stages, highlighting opportunities for more proactive education, self-management support and care coordination. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via (Ref. ID: 202610160830PR_NEWS_USPR_____LA73562) on October 16, 2026, and is solely responsible for the information contained therein. (C)